Chronic hepatitis B can now be treated with a new drug.
Known as the silent killer because it can persist for years without showing symptoms, chronic hepatitis B can now be treated with a new drug. Gilead Sciences' Viread (tenofovir disoproxil fumarate) was approved in 2001 to treat HIV. Chronic hepatitis B is a liver disease that disproportionately affects Asian Americans and is the leading cause of liver cancer worldwide. Complications from the disease can kill one in four of those affected.
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.